The headline is broadly defensible, but the qualifications matter. Effect sizes vary by population, the strongest claims rest on shorter trials, and credible voices push back on how it's typically framed.
there a was a rare occurrence of focal hyperpigment focal hyperpigmentation about 1% in the clinical trial when they used it more than eight times a month but we tell people probably to stick to four a month to limit that risk right and hypopigmentation at the injection site or just in general face gingiva breast like melan cour melan receptor sensitive tissue wow and it was in the clinical trial and it was seen in 1% of people
Every Sunday: the week’s new conflicts and verdict changes — and nothing else.
Native comments, Twitter mentions, and Reddit threads about this claim — surfaced together so the conversation isn't fragmented across platforms.
Bookmarking — the dossier-vs-overview split is the right call. Most of the time I want overview; sometimes I want receipts.
Would love a "what would change this verdict" RSS feed. Sign me up if it exists.